Grant: Discovery Grants Program - Individual
University of Manitoba
$34,000.00
Effect of Nipah virus infection on interferon type I (IFN-I) induction in porcine immune cells.
EF 2012-13
Résumé
Nipah virus is a zoonotic virus, requiring work in biosafety level 4 containment. The virus emerged in Malaysia in 1998 causing an outbreak of encephalitis in humans, with a 40% mortality rate. Recent outbreaks in Bangladesh are associated with human-to-human transmission, and 70% - 90% mortality rates. Although fruit bats are a reservoir of the virus, human infections in Malaysia were due to transmission of the virus from pigs. Since the disease in pigs resembles other swine diseases, if introduced into pigs, it could easily spread unrecognized, and spill over to humans. The consequences would be devastating on both human health and economic levels, as there are still no therapeutics or vaccines available. Very limited knowledge is available on Nipah virus infections in swine, although current defense strategy for human population is to provide a veterinary vaccine. Studies on protective immune response against Nipah virus in pigs at the University of Manitoba/ National Centre for Foreign Animal Disease suggested that the virus is evading the early immune response needed for antibody development, probably by blocking interferon production, beside other mechanisms. The group would like to better understand this aspect of Nipah virus infection in pigs, by studying NiV infection in porcine dendritic cells, and trying to determine how the virus blocks the interferon production. Conventional dendritic cells are antigen-presenting cells involved in stimulation of T cells, while the plasmacytoid dendritic cells are the most important interferon-alpha producing cells in early response to virus infection. Both cell types are important in initiation of development of the adaptive immune response.
Understanding of the role of interferon in the protection against the disease may lead to implementation of novel vaccination strategies (such as currently in development for foot-and-mouth disease), when rapid onset of immunity in pigs would be critical in protection of human population. These can be combined with more classical vaccination approaches, such as the canarypox vectored Nipah virus vaccine, our group tested in principle, and we will be proceeding with the efficacy testing in early 2012.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Manitoba, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
327187-2012
Name nom
Weingartl, Hana
Department département
Medical Microbiology & Infectious Diseases
Organization id
19
Institution établissement
University of Manitoba
Province en
Manitoba
Province fr
Manitoba
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2012
Award amount
34000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Virology
Research subject fr
Virologie
Partie
1
Nb partie
5
Application title
Effect of Nipah virus infection on interferon type I (IFN-I) induction in porcine immune cells.
Keyword
NSERC
Application summary
Nipah virus is a zoonotic virus, requiring work in biosafety level 4 containment. The virus emerged in Malaysia in 1998 causing an outbreak of encephalitis in humans, with a 40% mortality rate. Recent outbreaks in Bangladesh are associated with human-to-human transmission, and 70% - 90% mortality rates. Although fruit bats are a reservoir of the virus, human infections in Malaysia were due to transmission of the virus from pigs. Since the disease in pigs resembles other swine diseases, if introduced into pigs, it could easily spread unrecognized, and spill over to humans. The consequences would be devastating on both human health and economic levels, as there are still no therapeutics or vaccines available. Very limited knowledge is available on Nipah virus infections in swine, although current defense strategy for human population is to provide a veterinary vaccine. Studies on protective immune response against Nipah virus in pigs at the University of Manitoba/ National Centre for Foreign Animal Disease suggested that the virus is evading the early immune response needed for antibody development, probably by blocking interferon production, beside other mechanisms. The group would like to better understand this aspect of Nipah virus infection in pigs, by studying NiV infection in porcine dendritic cells, and trying to determine how the virus blocks the interferon production. Conventional dendritic cells are antigen-presenting cells involved in stimulation of T cells, while the plasmacytoid dendritic cells are the most important interferon-alpha producing cells in early response to virus infection. Both cell types are important in initiation of development of the adaptive immune response.
Understanding of the role of interferon in the protection against the disease may lead to implementation of novel vaccination strategies (such as currently in development for foot-and-mouth disease), when rapid onset of immunity in pigs would be critical in protection of human population. These can be combined with more classical vaccination approaches, such as the canarypox vectored Nipah virus vaccine, our group tested in principle, and we will be proceeding with the efficacy testing in early 2012.